Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

6.86
0.0000
Volume:- -
Turnover:- -
Market Cap:432.28M
PE:-7.79
High:6.86
Open:6.86
Low:6.86
Close:6.86
52wk High:8.01
52wk Low:0.2100
Shares:63.01M
Float Shares:11.45M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8810
EPS(LYR):-0.6309
ROE:--
ROA:--
PB:3.86
PE(LYR):-10.87

Loading ...

Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 25, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2020

Major Issues Report

8-K - Current report
Jun 29, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 29, 2020

Major Issues Report

8-K - Current report
Jun 29, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 15, 2020

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
May 15, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 14, 2020

Major Issues Report

8-K - Current report
Apr 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership